Novo will drop its U.S. list price for its Fiasp by 75% and for Tresiba by 72%, the Danish company said in a release. The new ...

Danish drug maker Novo Nordisk said on Thursday it will reduce the U.S. list prices of two insulin products by more than 70% ...

Why pay $84,000 for a hepatitis C drug when you can make it at home? But such DIY chemistry raises safety concerns ...

Indianapolis-based drugmaker Eli Lilly and Company has announced price reductions of 70% for its most commonly prescribed insulins, as well as expansion of its Insulin Value Program, capping ...

(AP Photo/Pablo Salinas) LOS ANGELES (CN) — A Superior Court judge, on Tuesday, told lawyers for the state of California that they would have to revise their lawsuit challenging insulin drug prices, ...

New Jersey patients deserve access to the best, affordable drugs our high-quality health care system has to offer. PBM reform is essential.

Oceanside's case joins scores of others, including those brought by several states, that allege ballooning insulin prices have caused them to overpay by hundreds of millions of dollars NBC ...

According to Frantz, the price of insulin has skyrocketed over the last two decades, going up from around $20 to now hitting the $400-$500 price range. CBS 8 reached out to several companies named ...

Gov. Kathy Hochul has signed legislation requiring New York health insurers to cover epipens for those who need them, and limit their annual total out-of-pocket costs to $100.

COPENHAGEN, Dec 5 (Reuters) - Danish drug maker Novo Nordisk (NOVOb.CO), opens new tab said on Thursday it will reduce the U.S. list prices of two insulin products by more than 70% from January of ...